Genetic variations trigger postnatal depression; risk could be identified with a new blood test developed by British scientists.
![British Scientists Develop New Screening Test to Identify Postnatal Depression Risk British Scientists Develop New Screening Test to Identify Postnatal Depression Risk](https://images.medindia.net/health-images/1200_1000/postnatal-depression-risk.jpg)
Postnatal depression is a type of depression some women experience after they have had a baby. It usually develops in the first four to six weeks after childbirth, but in some cases, it may take months to develop.
Postnatal depression is not the same as ‘baby blues’ which is a mild type of depression that occurs after childbirth and lasting from a few hours to a few days. During this time, the new mother may feel tearful and irritable, but no medical treatment is needed since in milder forms it is considered normal. However, if it is more prolonged and severe, it can develop into postnatal depression.
Symptoms of postnatal depression include low mood, feeling unable to cope and difficulty with sleeping. Unfortunately, many women are not aware they have the condition. Sometimes, the new mother may feel very agitated or alternatively very apathetic or have feelings of guilt and self-blame. She may even be thinking about harming self or the baby.
In view of this, the research is very important. ‘There is evidence that if you can identify women at risk early, you could treat early or introduce measures to prevent or stop the process of the disease,’ Grammatopoulos said.
Based on this research, Grammatopoulos and his team have developed the first ever blood test for postnatal depression which would allow women found to be at risk to receive treatment for the disease before they give birth.
‘Usually we focus on the mother, but the negative impact on the child is also immense,’ Prof Grammatopoulos said. He is now looking for further genetic changes to increase the predictive power of the test.
/S0022-3956%2813%2900143-X/abstract
Source-Medindia